Political Involvement

Our Political Principles and Positions

In its Bayer Group Regulation “Code of Conduct for Responsible Lobbying,” Bayer sets out clear and binding rules for its involvement in political matters, aiming to ensure transparency in any collaboration with the representatives of political institutions.

The Group’s Public and Governmental Affairs Committee is responsible for the strategic planning of Bayer’s political work. This especially includes developing the company’s political standpoints, as well as determining the position of the Bayer Board of Management on important political issues. In 2014 Bayer’s political lobbying again focused on the acceptance of products and technologies in society, on submitting proposals for creating sustainable health care systems, on chemicals and energy policy, and on climate protection. Bayer also actively promotes the protection of intellectual property in order to be able to continue developing innovative products.

Our liaison offices in Berlin, Brussels, Washington, Moscow, Brasilia and Beijing are key points of contact between the Group and the political arena. Bayer actively participates in existing transparency initiatives. It publishes details of costs, employee numbers and any of the other statistics required in each country, e.g. in the transparency registers of the European Parliament or the u.s. Congress. Bayer goes way beyond the statutory requirements in doing so. For instance, the Group also publishes data for countries, e.g. in Germany, where there is no legislative requirement to publish such information. In 2014 the costs incurred at the liaison offices for human resources, material and projects totaled approximately: €1.2 million in Berlin, €2.5 million in Brussels, €5 million in Washington, €0.25 million in Moscow and €1.2 million in Brasilia.

In keeping with our Group Regulation, we have committed not to make any direct donations to political parties, politicians or candidates for political office. However, some associations to which we belong make donations on their own initiative, in compliance with statutory regulations.

In the United States, a number of employees use the Bayer Corporation Political Action Committee (BayPac) to make private donations supporting candidates for congressional office. Political action committees in the United States are government-regulated, legally independent employee groups. In the United States, companies are legally prohibited from donating to political candidates directly. Consequently, such donations are not donations made by the company. The BayPac contributions are regularly reported to the u.s. Federal Election Commission and can be viewed on its website.

There are Five Areas in which Our Work is Most Affected by the Political Framework:

Innovation: Grundlage von Wachstum und Wohlstand

Innovation
Bayer boasts the largest research and development budget of the entire chemical and pharmaceutical industry in our home country, Germany. We support political frameworks that foster innovation. Since providing new benefits to society must be rewarded, this includes secure knowledge protection worldwide. In Germany, Bayer advocates the introduction of a tax credit for R&D investments.  more

Gesellschaftliche Akzeptanz für Technologien und Fortschritt

Social Acceptance of Technologies and Products
The welfare of societies is closely linked to the ability to develop and use new technologies. Bayer trusts in scientific research to determine the risks and benefits of technologies and products. It is in Bayer’s interest to provide safe solutions to today’s and tomorrow’s problems. Investments in technologies and production facilities span decades, though, and cost millions if not billions. Stable frameworks which make it possible to plan on such timescales are therefore essential to Bayer. This requires a broad and general acceptance of safe new technologies within societies. more

Nachhaltige Gesundheitssysteme

Sustainable Healthcare Systems
Societies all over the world are searching for new ways to organize their healthcare systems. The challenge is to keep costs under control while at the same time securing high-quality medical care and safeguarding the innovative strength of the pharmaceutical sector. As a pharmaceutical company Bayer has a view on how this can be achieved.  more

Energiepolitik und Umweltschutz

Energy Policy & Environmental Protection
Societies all over the world are searching for new ways to organize their healthcare systems. The challenge is to keep costs under control while at the same time securing high-quality medical care and safeguarding the innovative strength of the pharmaceutical sector. As a pharmaceutical company Bayer has a view on how this can be achieved. more

Chemikalienregulierung

Chemicals Regulation
Nearly all chemical products produced and traded by Bayer are registered according to such regulations as the European Union’s REACH legislation or the TSCA in the United States. Bayer acknowledges the importance of such legislation for the protection of human health and the environment and implements it accordingly. Chemicals regulation should be designed to be effective, but entail as little bureaucracy as possible. Bayer underlines the importance of a scientific approach to risk assessment. more

Last updated: July 17, 2015 Copyright © Bayer AG
http://www.bayer.com